Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-23

Clinical Trial Update: Contrast Ultrasound Detection of Sentinel Lymph Nodes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating contrast-enhanced ultrasound for detection of sentinel lymph nodes in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED